XFOR (X4 Pharmaceuticals, Inc.) Bozor qiymati
X4 Pharmaceuticals (XFOR) noyob patologiyalar uchun ichki dori ishlab chiqish sikliga tayanadi, bu esa iqtisodiy pasayishlarga chidamli mustaqil daromad oqimini yaratadi. Biroq, global fragmentatsiya xalqaro sinovlarni murakkablashtiradi va terapiya uchun xomashyo yetkazib berishni buzadi. Joriy ko'rsatkich 0.33 darajasida turibdi, GURU.Markets platformasidagi aktivning narx harakati esa likvidlik tanqisligi xatarlarini va nishiy mahsulotlarni tijoratlashtirishning murakkabliklarini hisobga oladi.
X4 Pharmaceuticals, Inc (XFOR) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- biznesning bozor baholash ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati X4 Pharmaceuticals|XFOR - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati X4 Pharmaceuticals|XFOR - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati X4 Pharmaceuticals, Inc|XFOR - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi X4 Pharmaceuticals|Tezkor likvidlik koeffitsiyenti x4pharma.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
XFOR - Sof foyda|Kelajakdagi foyda X4 Pharmaceuticals|XFOR - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori X4 Pharma|XFOR - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati X4 Pharmaceuticals, Inc|XFOR - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda X4 Pharmaceuticals|XFOR - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi x4pharma.com|XFOR - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi X4 Pharmaceuticals
Kompaniyaning fundamental tahlili:XFOR (X4 Pharmaceuticals, Inc.)
X4 Pharmaceuticals WHIM sindromi uchun tengsiz dori vositasini ishlab chiqqani sababli, kam uchraydigan immun patologiyalarini davolashda noyob o'rin tutadi. Barcha kompaniya aksiyalarining umumiy qiymati ushbu terapevtik salohiyatni aniq pul ekvivalentiga aylantiradi. Ushbu ko'rsatkich joriy aksiya narxini chiqarilgan aksiyalar soniga ko'paytirish orqali biznesning umumiy bozor qiymatini o'lchaydi. Ushbu metrikadagi keskin tebranishlar spekulyativ talabni yoki makroiqtisodiy omillarga bo'lgan reaksiyani anglatadi. Kompaniyaning bozor kapitalizatsiyasi dinamikasini tahlil qilish orqali investor fundamental o'sishni vaqtincha bozor shovqinlaridan ajratib olishi mumkin.
Muhim raqobatchilar
Bozor kapitallashuvi ARGX (argenx)|BNTX (BioNTech Inc.) - Bozor bahosi|ABVX - Bozor qiymati|Bozor qiymati ADMA Corp|Protagonist Therapeutics (PTGX) - Bozor qiymati|immunovant.com - Bozor qiymati|Bozor qiymati Kiniksa|Grifols SA - Bozor bahosi|Bozor kapitallashuvi ADPT|CLDX (Celldex Corp) - Bozor qiymati|Bozor kapitallashuvi AUPH (Aurinia Pharmaceuticals)|Bozor kapitallashuvi biocryst.com BCRX|VERA - Bozor qiymati|Bozor qiymati DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Bozor qiymati|Bozor bahosi AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Bozor kapitallashuvi|Bozor kapitallashuvi precigen.com|Bozor bahosi PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Bozor qiymati|Bozor kapitallashuvi UPB (Upstream Bio Corp)|Bozor kapitallashuvi Zenas Corp (ZBIO)|IMNM - Bozor qiymati|gossamerbio.com (GOSS) - Bozor bahosi|KalVista Pharmaceuticals, Inc. (KALV) - Bozor qiymati|Bozor bahosi Septerna, Inc.|Bozor bahosi PVLA|Bozor kapitallashuvi Savara Pharma|Bozor qiymati Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Bozor kapitallashuvi|Bozor kapitallashuvi ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Bozor qiymati|RAPT: Bozor bahosi|JBIO (Aerovate Therapeutics Inc) - Bozor kapitallashuvi|Bozor kapitallashuvi Aclaris Therapeutics|Bozor bahosi kyvernatx.com|TLSA - Bozor qiymati|Bozor qiymati CABA|VTYX - Bozor bahosi|Bozor kapitallashuvi Theratechnologies, Inc (THTX)|Bozor qiymati Avalo Therapeutics, Inc|Bozor kapitallashuvi eledon.com ELDN|Agenus Inc. - Bozor kapitallashuvi|CLYM: Bozor qiymati|Bozor qiymati Zura Bio ZURA|ATYR (aTyr Pharmaceuticals) - Bozor qiymati|Bozor bahosi ADAG|Bozor kapitallashuvi Ikena Oncology, Inc.|Bozor kapitallashuvi STTK|Bozor kapitallashuvi equilliumbio.com (EQ)|Connect Biopharma Holdings Limited - Bozor bahosi|Bozor kapitallashuvi Immunic Therapeutics IMUX|ATRA (Atara Biotherapeutics Inc) - Bozor qiymati|InflaRx N.V. (IFRX) - Bozor bahosi|ACET: Bozor kapitallashuvi|Bozor bahosi Celularity|INmune Bio Corp (INMB) - Bozor qiymati|Bozor kapitallashuvi Barinthus Biotherapeutics Corp|KZR (Kezar Life Sciences) - Bozor kapitallashuvi|Bozor kapitallashuvi sabbiotherapeutics.com (SABS)|Akari Therapeutics Plc - Bozor bahosi|Bozor kapitallashuvi Enlivex Therapeutics Ltd ENLV|Q32 Bio Corp - Bozor kapitallashuvi|GOVX: Bozor qiymati|Edesa Biotech, Inc. (EDSA) - Bozor qiymati|IBIO (ibioinc.com) - Bozor qiymati|CARM: Bozor kapitallashuvi|Bozor bahosi XTL Biopharmaceuticals Ltd (XTLB)|Bozor kapitallashuvi Bolt Biotherapeutics BOLT|Bozor kapitallashuvi hcwbiologics.com (HCWB)|Aptevo Therapeutics Inc. (APVO) - Bozor bahosi|aimimmuno.com - Bozor qiymati|ADTX (Aditxt Corp) - Bozor qiymati|GRI: Bozor qiymati|Bozor qiymati XORTX XRTX|HIND (Vyome Therapeutics) - Bozor qiymati|Bozor bahosi Revelation Biosciences REVB|Bozor kapitallashuvi indaptusrx.com|Scinai Immunotherapeutics Ltd. (SCNI) - Bozor qiymati|Bozor kapitallashuvi calcimedica.com (CALI)|Bozor kapitallashuvi AFMD (Affimed N.V.)|Allakos Inc - Bozor qiymati|Bozor qiymati HOOKIPA (HOOK)|IGMS: Bozor qiymati|ITOS (iTeos Therapeutics, Inc.) - Bozor bahosi|Ocean Biomedical Inc (OCEA) - Bozor kapitallashuvi|TCBP (TC BioPharm (Holdings) PLC) - Bozor kapitallashuvi|Bozor bahosi Third Harmonic Bio Inc (THRD)
